EUVIMEDEUVIMED entdecken
Crossref

Utilization of MRI-based radiomics nomogram for predicting HER2-zero, -low, and -overexpression breast cancer

Licui Zhang, Qinghong Duan, Ting Zhao, Jian He, Hongyang Li, Zhuoya Ma, Yong Wen, Ying Lei

Clinical and Translational Oncology · 09.03.2026 · 28 (9) · 3850-3861

DOI: 10.1007/s12094-026-04232-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, online erschienen am 09.03.2026. Verfasst von Licui Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Imaging, Guizhou Medical University, No.9, Beijing Road, Guiyang, 550000, Guizhou, China. Hauptthemen laut MEDLINE: Nomograms, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, Magnetic Resonance Imaging. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsErb-b2 Receptor Tyrosine KinasesBreast NeoplasmsMagnetic Resonance ImagingHumansRadiomicsFemaleRetrospective StudiesMiddle AgedDynamic Contrast Enhanced Magnetic Resonance ImagingAdultAged

Stichwörter der Autor:innen

Breast cancerHER2 expressionMRINomogramRadiomics

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • College of Medical Imaging, Guizhou Medical University, No.9, Beijing Road, Guiyang, 550000, Guizhou, China.
  • Department of Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, Guizhou, China.
  • Department of Radiology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, 550003, Guizhou, China.
  • College of Medical Imaging, Guizhou Medical University, No.9, Beijing Road, Guiyang, 550000, Guizhou, China. 45352500@qq.com.
  • Department of Radiology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, 550003, Guizhou, China. 45352500@qq.com.

Zitieren

APA

Zhang, L., Duan, Q., Zhao, T., He, J., Li, H., Ma, Z., Wen, Y., & Lei, Y. (2026). Utilization of MRI-based radiomics nomogram for predicting HER2-zero, -low, and -overexpression breast cancer. Clinical and Translational Oncology, 28(9), 3850-3861. https://doi.org/10.1007/s12094-026-04232-9

Vancouver

Zhang L, Duan Q, Zhao T, He J, Li H, Ma Z, et al. Utilization of MRI-based radiomics nomogram for predicting HER2-zero, -low, and -overexpression breast cancer. Clinical and Translational Oncology. 2026;28(9):3850-3861. doi:10.1007/s12094-026-04232-9

BibTeX
@article{Zhang2026,
  author = {Zhang, Licui and Duan, Qinghong and Zhao, Ting and He, Jian and Li, Hongyang and Ma, Zhuoya and Wen, Yong and Lei, Ying},
  title = {Utilization of MRI-based radiomics nomogram for predicting HER2-zero, -low, and -overexpression breast cancer},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  volume = {28},
  number = {9},
  pages = {3850--3861},
  doi = {10.1007/s12094-026-04232-9}
}
Kostenlos starten →